23rd June 2020 Neurolytic Healthcare

We are very excited and grateful to have been selected for the first global cohort of the Illumina Accelerator for genomics start ups! During the next six months we will continue developing high precision diagnostics & prescription tools to help migraine patients worldwide and push the boundaries of personalized medicine in neurological conditions.

Thank you to the Illumina team for their continued support!

To find out more please see the article on TechCrunch.